Diabetes Mellitus is Associated With Higher Serum Neurofilament Light Chain Levels in the General US Population

Renal Function and Body Mass Index Contribute to Serum Neurofilament Light Chain Levels in Elderly Patients With Atrial Fibrillation

(2022) Alexandros A. Polymeris et al.   Frontiers in Neuroscience

Factors influencing serum neurofilament light chain levels in normal aging

(2021) Marisa Koini et al.   Aging-US

Serum neurofilament light levels in normal aging and their association with morphologic brain changes

(2020) Michael Khalil et al.   Nature Communications

Prevalence of peripheral neuropathy in patients with diabetes: A systematic review and meta-analysis

(2020) Juan Sun et al.   Primary Care Diabetes

Type 3 Diabetes and Its Role Implications in Alzheimer’s Disease

(2020) Thuy Trang Nguyen et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

High Prevalence of Advanced Liver Fibrosis Assessed by Transient Elastography Among U.S. Adults With Type 2 Diabetes

(2020) Stefano Ciardullo et al.   DIABETES CARE

Renal function is associated with blood neurofilament light chain level in older adults

(2020) Shoshin Akamine et al.   Scientific Reports

Neurofilament light chain as a biomarker in neurological disorders

(2019) Lorenzo Gaetani et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Serum neurofilament light chain in chronic inflammatory demyelinating polyneuropathy

(2019) Gwen G. A. Lieverloo et al.   JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM

Diabetes mellitus and risks of cognitive impairment and dementia: A systematic review and meta-analysis of 144 prospective studies

(2019) Mei Xue et al.   AGEING RESEARCH REVIEWS

2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2020

(2019)   DIABETES CARE

Neurofilaments as biomarkers in neurological disorders

(2018) Michael Khalil et al.   Nature Reviews Neurology

The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases

(2017) Naga Chalasani et al.   HEPATOLOGY

Neurofilament Light Chain in Blood and CSF as Marker of Disease Progression in Mouse Models and in Neurodegenerative Diseases

(2016) Mehtap Bacioglu et al.   NEURON

Impact of diabetes on cognitive function and brain structure

(2015) Amir Moheet et al.   Annals of the New York Academy of Sciences

Type 2 diabetes mellitus and biomarkers of neurodegeneration

(2015) Chris Moran et al.   NEUROLOGY

Diabetes in Midlife and Cognitive Change Over 20 Years

(2014) Andreea M. Rawlings et al.   ANNALS OF INTERNAL MEDICINE

Diabetes as a risk factor for stroke in women compared with men: a systematic review and meta-analysis of 64 cohorts, including 775 385 individuals and 12 539 strokes

(2014) Sanne A E Peters et al.   LANCET

Review on intermediate filaments of the nervous system and their pathological alterations

(2013) Claire Lépinoux-Chambaud et al.   HISTOCHEMISTRY AND CELL BIOLOGY

Diabetes as a risk factor for dementia and mild cognitive impairment: a meta-analysis of longitudinal studies

(2012) G. Cheng et al.   INTERNAL MEDICINE JOURNAL

Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity, and Treatments

(2010) S. Tesfaye et al.   DIABETES CARE

Longitudinal Verbal Fluency in Normal Aging, Preclinical, and Prevalent Alzheimer’s Disease

(2009) Linda J. Clark et al.   American Journal of Alzheimers Disease and Other Dementias

Vitamin D, a neuro-immunomodulator: Implications for neurodegenerative and autoimmune diseases

(2009) D.A. Fernandes de Abreu et al.   PSYCHONEUROENDOCRINOLOGY

Consortium to Establish a Registry for Alzheimer’s Disease (CERAD): The first twenty years

(2008) Gerda G. Fillenbaum et al.   Alzheimers & Dementia